Patent Download Websites

Download Websites

http://patentscope.wipo.int/search/en/search.jsf

http://patentscope.wipo.int/search/zh/search.jsf

http://patft.uspto.gov/
(US Patent and Trademark Office ， USPTO)

http://www.pat2pdf.org/

http://worldwide.espacenet.com/ 

http://www.drugfuture.com/cnpat/cn_patent.asp
(Free Chinese Patent Search and download)

http://www.drugfuture.com/uspat/us_patent.asp

http://search.sipo.gov.cn/sipo/zljs/searchflzt.jsp
 (chinese patent search provided by state intellectual property office of china)

http://www.soopat.com/
SooPAT

http://so.5ipatent.com/

http://www.chemyq.com/patent.htm
(read online for free full length of Chinese patents published since september, 1985)

http://www.epatents.gov.sg/PE/

http://www.ultra-patent.jp/Search/Search+.aspx

http://www.jpo.go.jp
 (Free Japanese Patent Search)

http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/introduction.html

http://eng.kipris.or.kr/eng/main/main_eng.jsp
（Korean patent search)

http://www.freepatentsonline.com/search.html
freepatentsonline

http://www.patentlens.net/patentlens/quick.html?noScroll

http://pay.patentfetcher.com/Patent-Fetcher-Form.php

http://www.patentics.com/indexcn.htm

http://www.google.com/patents
(free google patent search and download)

http://zhuanli.baidu.com/

http://pat365.com/search.jsp 
(Search patents from Taiwan)

http://www.patentstorm.us/

http://www.zhihuiya.com/  

United States Patent and Trademark Office ….. published and made electronically available a new edition of the Manual of Patent Examining Procedure (MPEP

United States Patent and Trademark Office

Today we published and made electronically available a new edition of the Manual of Patent Examining Procedure (MPEP).

Manual of Patent Examining Procedure

uspto.gov

http://www.uspto.gov/web/offices/pac/mpep/index.html

Manual of Patent Examining Procedure (MPEP)Ninth Edition, March 2014

The USPTO continues to offer an online discussion tool for commenting on selected chapters of the Manual. To participate in the discussion and to contribute your ideas go to: http://uspto-mpep.ideascale.com.

Share this:

USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation?

USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation?

http://commercialbiotechnology.com/index.php/jcb/article/view/664
Abstract

In June 2013, the U.S. Supreme Court issued a unanimous decision upending more than three decades worth of established patent practice when it ruled that isolated gene sequences are no longer patentable subject matter under 35 U.S.C. Section 101.While many practitioners in the field believed that the USPTO would interpret the decision narrowly, the USPTO actually expanded the scope of the decision when it issued its guidelines for determining whether an invention satisfies Section 101. The guidelines were met with intense backlash with many arguing that they unnecessarily expanded the scope of the Supreme Court cases in a way that could unduly restrict the scope of patentable subject matter, weaken the U.S. patent system, and create a disincentive to innovation. By undermining patentable subject matter in this way, the guidelines may end up harming not only the companies that patent medical innovations, but also the patients who need medical care. This article examines the guidelines and their impact on various technologies.

How Long Is A Drug Patent Good For?

Patents are good for 20 years after the invention of a drug–not after the drug comes to market. It can easily take eight years for the pharmaceutical companies to gather enough data to get approval for their new invention from the U.S. Food and Drug Administration. Meanwhile the FDA can send the drug company back for more clinical studies  (experiments using humans as subjects to test the drugs’ efficacy and side effects) and more data, and all the while the patent clock is ticking.

That’s why the name of the game for pharmaceutical companies is working to extend those patents for a top-selling drug

read all at

How Long Is A Drug Patent Good For? – Drugsdb.com http://www.drugsdb.com/blog/how-long-is-a-drug-patent-good-for.html#ixzz2evb9L5rn

CRASH COURSE ON PATENTS

https://sites.google.com/site/patentrelatedsite/crash-course-on-patents

CHEMICAL PATENT

Example of a Markush structure

A chemical patent, pharmaceutical patent or drug patent is a patent for an invention in the chemical or pharmaceuticals industry. Strictly speaking, in most jurisdictions, there are essentially no differences between the legal requirements to obtain a patent for an invention in the chemical or pharmaceutical fields, in comparison to obtaining a patent in the other fields, such as in the mechanical field. A chemical patent or a pharmaceutical patent is therefore not a sui generis right, i.e. a special legal type of patent.

In the pharmaceutical industry, the patent protection of drugs and medicines is accorded a particular importance, because drugs and medicines can easily be copied or imitated (by analyzing a pharmaceutical substance) and because of the significant research and development spending and the high risks associated with the development of a new drug.^[1][2][3]

Chemical patents are different from other sources of technical information because of the generic, Markush structures contained within them, named after the inventor Eugene Markush who won a claim in the US in 1925 to allow such structures to be used in patent claims. These generic structures are used to make the patent claim as broad as possible.

Patent law
Overviews
Patents History Economics Societal views
Basic concepts
Application Prosecution Licensing Infringement Valuation
Patentability
Novelty Inventive step and non-obviousness Inventorship Industrial applicability Patentable subject matter Person skilled in the art Prior art Utility
Additional requirements
Sufficiency of disclosure Unity of invention
By region / country
Patent Cooperation Treaty Australia Canada China Europe Germany Japan United States
By specific subject matter
Biological Business method Chemical Insurance Software Tax
See also
Category Glossary

See also

• Compulsory licensing (patents)
• Criticism of pharmaceutical patents
• Evergreening
• Generic drug
• Supplementary protection certificate

References

1.  Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz, Leading Pharmaceutical Innovation, Trends and Drivers for Growth in the Pharmaceutical Industry, Springer, 2008, ISBN 3-540-77635-4, ISBN 978-3-540-77635-2, pages 133-134.
2.  Scherer FM., The economics of human gene patents, Acad Med. 2002 Dec;77(12 Pt 2):1348-67 : "

Further reading

• European Commission, Pharmaceuticals, Sector Inquiry, 2008 (Public Consultation, Preliminary Report).
• "Patents and Pharmaceuticals", a paper given on 29 November 2008 at the Presentation of the Directorate-General of Competition’s Preliminary Report of the Pharma-sector inquiry, by the Rt. Hon. Sir Robin Jacob
• India wins landmark patent battle, BBC News, March 9, 2005
• "HIV/AIDS, Patents and the TRIPS Agreement: Issues and Options", United States Congressional Research Service, July 27, 2001
• "Pharmaceutical Patent Term Extensions: A Brief Explanation", United States Congressional Research Service, January 31, 2002

External links[edit]

• Patent Opposition Database, an online resource launched by Doctors without Borders as "a tool which can be used to explore how to challenge unfair patents and their negative impact on access to medicines." ("About". Patent Opposition Database. MSF Access Campaign. Retrieved October 13, 2012.)

..........
SHIMOGA,  KARNATAKA, INDIA

Shimoga - Wikipedia, the free encyclopedia

en.wikipedia.org/wiki/Shimoga

Shimoga, officially renamed as Shivamogga, is a city and the district headquarters of Shimoga District in the central part of the state of Karnataka, India. The city ...

‎Shimoga district - ‎Shimoga Airport - ‎Category:Shimoga

.


Shimoga–Talaguppa railway

Kundadri, Shimoga

Shimoga Photos - Kudli Temple






Ornate baluster in Thripuranthakeshwara temple at Balligavi, Shimoga district.jpg



sigandur - Shimoga

////////

An Overview of Patent Strategy

read at

https://sites.google.com/site/patentrelatedsite/an-overview-of-patent-strategy